Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Higher serum galactose-deficient immunoglobulin A1 concentration is associated with stronger mesangial cellular inflammatory response and more severe histologic findings in immunoglobulin A nephropathy.
Nguyen C, König K, Tam FWK, Hopfer H, Molyneux K, Binet FI, Kim MJ. Nguyen C, et al. Among authors: molyneux k. Clin Kidney J. 2018 Aug 3;12(2):232-238. doi: 10.1093/ckj/sfy068. eCollection 2019 Apr. Clin Kidney J. 2018. PMID: 30976401 Free PMC article.
An update on the pathogenesis and treatment of IgA nephropathy.
Boyd JK, Cheung CK, Molyneux K, Feehally J, Barratt J. Boyd JK, et al. Among authors: molyneux k. Kidney Int. 2012 May;81(9):833-43. doi: 10.1038/ki.2011.501. Epub 2012 Feb 8. Kidney Int. 2012. PMID: 22318424 Free article. Review.
Spleen tyrosine kinase is important in the production of proinflammatory cytokines and cell proliferation in human mesangial cells following stimulation with IgA1 isolated from IgA nephropathy patients.
Kim MJ, McDaid JP, McAdoo SP, Barratt J, Molyneux K, Masuda ES, Pusey CD, Tam FW. Kim MJ, et al. Among authors: molyneux k. J Immunol. 2012 Oct 1;189(7):3751-8. doi: 10.4049/jimmunol.1102603. Epub 2012 Sep 5. J Immunol. 2012. PMID: 22956578 Clinical Trial.
Differential expression of microRNA miR-150-5p in IgA nephropathy as a potential mediator and marker of disease progression.
Pawluczyk IZA, Didangelos A, Barbour SJ, Er L, Becker JU, Martin R, Taylor S, Bhachu JS, Lyons EG, Jenkins RH, Fraser D, Molyneux K, Perales-Patón J, Saez-Rodriguez J, Barratt J. Pawluczyk IZA, et al. Among authors: molyneux k. Kidney Int. 2021 May;99(5):1127-1139. doi: 10.1016/j.kint.2020.12.028. Epub 2021 Jan 6. Kidney Int. 2021. PMID: 33417998 Free article.
Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial.
Wimbury D, Muto M, Bhachu JS, Scionti K, Brown J, Molyneux K, Seikrit C, Maixnerová D, Pérez-Alós L, Garred P, Floege J, Tesař V, Fellstrom B, Coppo R, Barratt J. Wimbury D, et al. Among authors: molyneux k. Kidney Int. 2024 Feb;105(2):381-388. doi: 10.1016/j.kint.2023.11.003. Epub 2023 Nov 25. Kidney Int. 2024. PMID: 38008160 Free article. No abstract available.
34 results